Listen "Q & A With the Author (Scuccimarri et al)"
Episode Synopsis
Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic
Rosie Scuccimarri, Evelyn Sutton and Mary-Ann Fitzcharles
DOI: https://doi.org/10.3899/jrheum.200369
Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past 70 years. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of the coronavirus (SARS-CoV2)–associated disease called COVID-19.
Rosie Scuccimarri, Evelyn Sutton and Mary-Ann Fitzcharles
DOI: https://doi.org/10.3899/jrheum.200369
Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past 70 years. These agents have attracted intense media attention in the past few weeks with suggestions that this category of drugs may have potential in the management of the coronavirus (SARS-CoV2)–associated disease called COVID-19.
More episodes of the podcast The JRHEUM Podcast
October 2025 Editor's Summary
01/10/2025
September 2025 Editor's Summary
02/09/2025
August 2025 Editor's Summary
01/08/2025
July 2025 Editor's Summary
02/07/2025
June 2025 Editor's Summary
02/06/2025
May 2025 Editor's Summary
30/04/2025
April 2025 Editor's Summary
30/03/2025
March 2025 Editor's Summary
26/02/2025
February 2025 Editor's Summary
30/01/2025
January 2025 Editor's Summary
29/12/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.